retatrutide clinical trial thailand SURMOUNT-1 Tirzepatide — 22.5% Weight Loss patientsafety #publichealth #healthcareleadership #medicalethics #drugsafety

Broader condition context is available in the Type 2 Diabetes collection

71 These data, together with the finding of no effect of prior weight-reduction strategies on hard outcomes in HF, signify very likely beneficial effects of GLP-1RAs that are independent of weight loss

CrossRef Association between vitamin D and metabolic-associated steatotic liver disease in type 2 diabetes mellitus patients: a systematic review and meta-analysis Bruno Basil, Winifred Adiri, Ejike Lawrence Ugwu, Ngozi Ijeoma Okoro Diabetology & Metabolic Syndrome .2025;[Epub] CrossRef Association between atherosclerosis-related indicators and fatty liver: a population-based observational study Xiaoping Liu, Ping Yuan, Ying Huang European Journal of Medical Research .2025;[Epub] CrossRef Associations Between Systemic Inflammatory Markers, Metabolic Dysfunction, and Liver Fibrosis Scores in Patients with MASLD Ragaey Ahmad Eid, Ahmed Moheyeldien Hamed, Sara O

They are different molecules with different mechanisms, different efficacy profiles, and different regulatory statuses